Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.

American journal of clinical oncology - 1 Dec 2021

Punekar Salman R, Griffin Megan M, Masri Lena, Roman Stefanie D, Makarov Danil V, Sherman Scott E, Becker Daniel J

Abstract excerpt

OBJECTIVES: Treatment with epidermal growth factor receptor monoclonal antibodies extends life for patients with advanced colorectal cancers (CRCs) whose tumors exhibit wild-type KRAS, but KRAS testing may be underused. We studied the role of socioeconomic factors in the application of KRAS testing. MATERIALS AND METHODS: We identified subjects with stage IV colorectal adenocarcinoma diagnosed 2010-2015 in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Multivariate Analysis

Share to Precision Medicine

Share to Proto-Oncogene Proteins p21(ras)

Share to SEER Program

Share to Socioeconomic Factors

Source

Identifiers

PMID: 34753883
DOI: 10.1097/COC.0000000000000875

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.PMID 34753883Read ↗

Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.Semantic proximity Read ↗

Biomarker Testing Disparities in Metastatic Colorectal CancerSemantic proximity Read ↗

Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia.Semantic proximity Read ↗

KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.Semantic proximity Read ↗

Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer.Semantic proximity Read ↗

Racial Differences in Stage IV Colorectal Cancer Molecular Profiling and Mutation Rates.Semantic proximity Read ↗

KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis.Semantic proximity Read ↗

Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data.Semantic proximity Read ↗

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Semantic proximity Read ↗

Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey.Semantic proximity Read ↗

Are There Socio-Demographic Inequalities in the Utilisation of Tumour and ctDNA Somatic Mutation Testing in Solid Tumours? A Systematic Review.Semantic proximity Read ↗

Survivability in Patients with Rare Colorectal Adenocarcinoma Variants: Exploring the Influence of Rural-Urban Continuum Codes and Social Determinants of Health in the United StatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.